Metraipolis › archive › dc_c6ca92b080ad

EgLDH as a Novel Target: Design and Preliminary Efficacy Assessment of a DNA Vaccine — Europe PMC PMID:41751016

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41751016
DOI
10.3390/ani16040555
License (as archived)
solo-consultazione
Archived
2026-11-05T22:19:00.132Z
SHA-256 of the archived text
536052f6fdbc4f9657c972bd33955f86248e7198e02a1d4903fe30f27a6c1755
Stable URL of this page
https://metraipolis.com/documento/dc_c6ca92b080ad

How to cite

EgLDH as a Novel Target: Design and Preliminary Efficacy Assessment of a DNA Vaccine — Europe PMC PMID:41751016 — Europe PMC (en), https://europepmc.org/article/MED/41751016 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c6ca92b080ad (Metraipolis archive dc_c6ca92b080ad, sha256 536052f6fdbc4f9657c972bd33955f86248e7198e02a1d4903fe30f27a6c1755)
BibTeX
@misc{dcc6ca92b080ad,
  title = {EgLDH as a Novel Target: Design and Preliminary Efficacy Assessment of a DNA Vaccine — Europe PMC PMID:41751016},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41751016},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c6ca92b080ad; sha256 536052f6fdbc4f9657c972bd33955f86248e7198e02a1d4903fe30f27a6c1755},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751016. Agents can read the archived copy with the MCP tool read_document.